Olaparib With Ceralasertib in Recurrent Osteosarcoma

Conditions:   Osteosarcoma;   Osteosarcoma Recurrent Interventions:   Drug: Olaparib;   Drug: Ceralasertib Sponsors:   Dana-Farber Cancer Institute;   Osteosarcoma Institute;   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials